Status:
COMPLETED
The Kabeho Study: Kigali Antiretroviral and Breastfeeding Assessment for the Elimination of HIV
Lead Sponsor:
Elizabeth Glaser Pediatric AIDS Foundation
Collaborating Sponsors:
Ministry of Health, Rwanda
University of Rwanda
Conditions:
Mother-to-child HIV Transmission
Eligibility:
FEMALE
Brief Summary
The study design includes an observational prospective cohort of HIV-positive pregnant/postpartum women and their infants enrolled during antenatal clinics (or immediately postpartum) from prevention ...
Eligibility Criteria
Inclusion
- Documented HIV infection
- Pregnant, in the last trimester of pregnancy or within two weeks post-delivery.
- Participation in the PMTCT program during antenatal care at one of the study sites
- Planning on remaining in the Kigali area after delivery
- Able and willing to give informed consent for study participation for herself and her infant(s).
- If a pregnant woman is less than 18 years of age and still living with her parents, informed consent will also be required from one of her parents
Exclusion
- Women not willing to provide informed consent to participate
Key Trial Info
Start Date :
April 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
1216 Patients enrolled
Trial Details
Trial ID
NCT02295800
Start Date
April 1 2013
End Date
December 1 2016
Last Update
January 4 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Elizabeth Glaser Pediatric AIDS Foundation
Kigali, Rwanda, BP 2788